 San Francisco, California -- Artificial intelligence technology company Atomwise has landed $6 million in new venture capital funding.
Atomwise is developing an AI system to improve and speed up drug discovery.
The system uses learning algorithms and supercomputers to analyze millions of potential medicines each day.
Data Collective led the round which included other undisclosed investors.
The company did not say how the financing proceeds would be used. |